$39.99
+0.07 (+0.18%)
Open$39.91
Previous Close$39.92
Day High$40.34
Day Low$39.85
52W High$54.85
52W Low$28.54
Volume—
Avg Volume429.5K
Market Cap1.51B
P/E Ratio—
EPS$-0.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-38.4% upside
Current
$39.99
$39.99
Target
$24.64
$24.64
$15.17
$24.64 avg
$37.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 279.22M | 192.05M | 753.50M |
| Net Income | -5,269,698 | -3,262,073 | 117.60M |
| Profit Margin | -1.9% | -1.8% | 15.6% |
| EBITDA | 25.31M | 16.54M | 185.25M |
| Free Cash Flow | — | — | 80.89M |
| Rev Growth | +45.4% | +45.4% | +23.8% |
| Debt/Equity | 4.64 | 4.64 | 0.62 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |